Organization Profile

You just read:

ViiV Healthcare receives approval for Triumeq™ (dolutegravir/abacavir/lamivudine), in Canada - a new once-daily single-pill regimen for the treatment of HIV

News provided by

ViiV Healthcare

Oct 14, 2014, 13:33 ET